Expand All | Collapse All
Victor Kim, MD, Chair
Dr. Kim, who is board certified by the American Board of Internal Medicine (ABIM) in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine, is an Associate Professor of Medicine in the Department of Thoracic Medicine and Surgery at Temple University School of Medicine.
Previously, he was an Assistant Professor of Medicine at Temple University School of Medicine and an Instructor at Thomas Jefferson University Hospital. Dr. Kim has been active in medical student education and was co-Director of the pulmonary pathophysiology course for Temple University School of Medicine. He also lectures to the Temple University School of Podiatry on pulmonary disease. He also served as Chief Medical Resident at Thomas Jefferson University.
Dr. Kim currently serves as an Associate Editor of both the Annals of the American Thoracic Society and BMC Pulmonary Medicine, and is a member of the Editorial Board of the Journal of the COPD Foundation. He is currently grant funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health to study chronic bronchitis, goblet cell hyperplasia and inflammation in chronic obstructive pulmonary disease. He is the Chair of ABIM's Critical Care Medicine Board Exam Committee.
Dr. Kim trained as a fellow in pulmonary, critical care and sleep medicine at Temple University, and as a resident at Thomas Jefferson University. He received his medical degree from the University of Pittsburgh, and his bachelor's degree from Johns Hopkins University where he graduated with honors and was elected to Phi Beta Kappa. He received the Sol Sherry Award for Excellence in Research during fellowship, and the Outstanding Teaching Resident Award during residency.
As of January 2017, Dr. Kim reported the following external relationships:
Attendance at investigators’ meetings, with compensation for travel expenses from the following companies:
- COPDGene, receiving travel reimbursement.
- SPIROMICS, receiving travel reimbursement.
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- AstraZeneca, for development of new drugs.
- Gala Therapeutics, for development of a new bronchoscopic treatment for chronic bronchitis.
Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:
- Concert Pharmaceuticals, for consulting on new drug development for chronic bronchitis.
Amy G. Agrawal, MD
Dr. Agrawal is board certified in Internal Medicine and Critical Care Medicine. She currently practices critical care medicine as a member of Capital Critical Care, LLC at Holy Cross Hospital, a large community hospital in Silver Spring, Maryland.
Previously, Dr. Agrawal was a Staff Clinician at the National Institutes of Health (NIH). In addition to clinical duties in the Intensive Care Unit of the NIH Clinical Center, she initiated and developed the Clinical Simulation Program. As its first Director, she designed simulation/immersion curricula using computerized mannequins for teaching of critical competencies to physicians, nurses and respiratory therapists. Using techniques borrowed from safety training in the airline industry, participants would act “on the spot” and then be led through reflective debriefings afterwards, reinforcing key principles of team dynamics and patient safety.
Her research interest at NIH was West Nile virus. Dr. Agrawal was the Study Chair of an NIH-funded multicenter (U.S. and Canada) trial assessing response to specific anti-West Nile antibody versus placebo in subjects with early encephalitis or myelitis. Following that role, she acted as a consultant for a biotechnology company, assembling (and acting as a member of) scientific advisory board for development of humanized monoclonal antibody versus West Nile virus. She is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee.
Dr. Agrawal trained in critical care medicine at NIH and in infectious diseases at Johns Hopkins University. Her internal medicine training was at Georgetown University Hospital, and her medical degree is from Vanderbilt University.
As of April 2019, Dr. Agrawal reported no ongoing external relationships.
Christopher F. Barnett, MD
Dr. Barnett is Director of the Pulmonary Hypertension Program and Director of the Medical Cardiovascular Intensive Care Unit at MedStar Heart & Vascular Institute at MedStar Washington Hospital Center. He is board certified in critical care medicine, cardiovascular disease, and advanced heart failure and transplant cardiology. He is a member of the International Society for Heart & Lung Transplantation, the American College of Cardiology, and the Pulmonary Hypertension Association. Previously, Dr. Barnett was Associate Professor of Medicine at the University of California, San Francisco, where he was a member of the Cardiology Division of San Francisco General Hospital.
Dr. Barnett specializes in the care of patients with pulmonary hypertension as well as patients who are critically ill with cardiovascular disease. In his pulmonary hypertension practice, he manages patients with advanced therapies including parenteral treatments. In the cardiac intensive care unit, he leads a multidisciplinary team that provides optimal, collaborative care to patients with severe cardiovascular disease as well as to patients before and after advanced, special cardiovascular procedures. He works closely and collaboratively with referring providers and other specialist physicians, including transplant cardiologists and the palliative care team at MedStar Washington Hospital Center.
Dr. Barnett is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee.
Dr. Barnett received his medical degree and his master's degree in public health from Northwestern University. He completed his internal medicine residency at Northwestern Memorial Hospital in Chicago, Illinois. He then completed a clinical and research fellowship in critical care medicine at the National Institutes of Health (NIH), followed by a fellowship in cardiovascular disease at the University of California, San Diego. He joined the faculty at the University of California, San Francisco, where he became Associate Professor of Medicine, prior to joining MedStar.
As of March 2019, Dr. Barnett reported the following external relationships.
Funding for clinical trial expenses and staff, paid to Mestar Washingston Hospital Center, from the following companies:
- Complexa, funding for a study of two doses of oral CXA-10 in pulmonary arterial hypertension.
- United Therapeutics, funding for two studies evaluating the safety and efficacy of inhaled treprostinil in subjects with pre-capillary pulmonary hypertension.
Teaching in satellite symposia funded by the following companies, without compensation:
- Pulmonary Embolism Response Team Consortium, moderated a session on pulmonary embolism at Cardiovascular Research Technologies meeting.
Alain Broccard, MD
Dr. Broccard currently serves as the Medical Director for St. Vincent Seton Specialty Hospital located in Indianapolis. He is board certified in Internal Medicine, Critical Care Medicine, Pulmonary Disease and Sleep Medicine.
Previously, Dr. Broccard was Chairman of the Pulmonary and Critical Care Department at Vassar Brothers Medical Center in Poughkeepsie, New York. Prior to this appointment, he served as Professor of Medicine at the University of Minnesota where he developed and led the Critical Care and Respiratory Therapy Services at Fairview Southdale Hospital in Edina, Minnesota. Before this latter position, Dr. Broccard was the MICU Medical Director and subsequently Critical Care Section Head for Regions Hospital in St. Paul, Minnesota.
Dr. Broccard is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, he has served on various committees of the American Thoracic Society. He has received multiple awards from the Swiss Intensive Care Society and from the University of Minnesota Medical School. Dr. Broccard was a reviewer for major United States and European critical care journals and was on the editorial board of the American Journal of Respiratory and Critical Care Medicine. He has extensively published on ventilator-induced lung injury and has been an invited lecturer at major international critical care society meetings and institutions both in the United States and abroad.
Dr. Broccard received his medical degree from the University of Geneva Medical School, Switzerland. He completed his house staff training at Geneva University Hospital and further critical care training at Lausanne University Hospital, Switzerland. He subsequently completed pulmonary and critical care fellowships at the University of Minnesota and at the Mayo Clinic in Rochester, Minnesota.
As of February 2019, Dr. Broccard reported no external relationships.
Cherylee W. J. Chang, MD
Dr. Chang has been the Medical Director of the Neuroscience Institute and Neurocritical Care at The Queen’s Medical Center (QMC) in Honolulu, Hawaii, since 1999. She also founded and directed the stroke center at the QMC which was a TJC-certified Primary Stroke Center from 2004-2016. In 2016, the facility became a TJC-certified Comprehensive Stroke Center. In May 2017, Dr. Chang named a successor to the directorship and stepped down from that role after directing the stroke center for 20 years.
She currently has dual appointments as a Clinical Professor of Medicine and Surgery at the John A. Burns School of Medicine at the University of Hawaii. Dr. Chang is board certified in Neurology, Critical Care Medicine and Neurocritical Care.
Prior to her arrival in Honolulu, she was an Assistant Clinical Professor of Medicine at the University of California (UC), San Diego.
Dr. Chang is a member of the Critical Care Medicine Board Exam Committee for the American Board of Internal Medicine. She currently serves as the Neuroscience Representative for the Council of the Society of Critical Care Medicine. She served as the third president of the Neurocritical Care Society from 2007 to 2009 and served in a leadership role in creating certification of individuals and accreditation of fellowship training programs in neurological critical care. She chaired the United Council of Neurological Specialties Neurointensive Care Examination Committee for its inauguration and several years thereafter. She is a member of the Board of Directors of the Rehabilitation Hospital of the Pacific and is Chair of the Board’s Quality Improvement Committee.
Dr. Chang received her bachelor’s degree in biological sciences with honors and distinction from Stanford University. She completed her medical degree at (UC) San Diego, and finished residencies in neurology and internal medicine at Stanford University Medical Center and UC San Diego respectively. She completed joint fellowships in critical care medicine and neurocritical care at the University of Virginia. Dr. Chang has achieved the level of Fellow in the American College of Critical Care Medicine, the American College of Physicians and the Neurocritical Care Society.
As of July 2017, Dr. Chang reported the following external relationships.
Funding for clinical trial expenses and staff, paid directly to the Queen’s Medical Center, from the following companies:
- Janssen, the ARAMIS trial (Addressing Real-world Anticoagulant Management Issues in Stroke) that is a registry cosponsored by Janssen, LP; Genentech, Inc.; and Daiichi Sankyo Inc., in collaboration with Duke University and the American Heart Association that is designed to look at the prevalence of the direct-acting oral anticoagulants in patients admitted with acute ischemic stroke or intracerebral hemorrhage.
- Sage Therapeutics, a phase 3 trial of allopregnanolone, a neuroactive steroid to treat super-refractory status epilepticus.
- University of Miami and the American Heart Association, the MaRISS trial (Mild and Rapidly Improving Stroke Study) is an observational patient registry evaluating patients with mild or rapidly improving stroke for 90 days to evaluate outcomes, including disability and hemorrhage rates associated with intravenous thrombolysis.
Attendance at investigators’ meetings, with compensation for travel expenses from the following company:
- Sage Therapeutics, a phase 3 trial of allopregnanolone, a neuroactive steroid to treat super-refractory status epilepticus, no compensation at this time.
Dr. Chang serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Legacy of Life Hawaii, member of Advisory Board of the Hawaii state organ procurement organization, helping to oversee quality issues and strategic needs, receiving no compensation.
- Neurocritical Care Society, Past President, attends some Board meetings and strategic planning meetings, also providing occasional lectures, receiving reimbursement for travel and other expenses.
- Rehabilitation Hospital of the Pacific, member of Board of Directors and Chair of the Board Quality Improvement Committee to oversee quality and patient safety issues, receiving no compensation.
- Society of Critical Care Medicine, serving as co-Chair of the 2017 Annual Congress for SCCM; elected in 2016 to the SCCM Council as the neuroscience representative, receiving reimbursement for travel and other expenses.
Gina M. Iacovella, MD
Dr. Iacovella is an intensivist for the Intensive Care Consortium at Brandon Regional Hospital in Brandon, Florida, which is an affiliate teaching hospital of the University of South Florida. She is board certified in Internal Medicine, Nephrology and Critical Care Medicine.
Previously, Dr. Iacovella worked at Lakeland Regional Hospital in Lakeland, Florida as an intensivist caring for a large underserved population at a Level II Trauma Center.
Dr. Iacovella is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, she is an active member of both the American Society of Nephrology and the Society of Critical Care Medicine.
Dr. Iacovella received both her undergraduate degree in biology and master’s degree in bio-analytical chemistry from the University of South Carolina in Columbia, South Carolina. She earned her medical doctorate at the Medical University of South Carolina in Charleston, South Carolina. Dr. Iacovella completed internal medicine residency at Cedars-Sinai Medical Center in Los Angeles, California, a fellowship in nephrology at Yale University in New Haven, Connecticut and a fellowship in critical care medicine at Mayo Clinic in Rochester, Minnesota.
As of August 2017, Dr. Iacovella reported no external relationships:
John R. McArdle, MD
Dr. McArdle, who is board certified in internal medicine, pulmonary disease, and critical care medicine, is employed in the full-time clinical practice of pulmonary and critical care medicine for Starling Physicians, PC. He is also chief of the pulmonary division at Hartford Hospital and his co-director of the Marie and Raymond Beauregard Central Connecticut Adult Cystic Fibrosis Program.
Previously, Dr. McArdle was an associate professor of medicine at Yale University School of Medicine in the section of Pulmonary and Critical Care Medicine. He directed the Yale Adult Cystic Fibrosis Program, served as medical director of the medical intensive care unit, and was clerkship director for the Yale University School of Medicine Internal Medicine clerkship.
He is a former president of the Connecticut pulmonary section of the American lung Association, and is a member of the American Board of internal medicines Critical Care examination committee.
Dr. McArdle received the Yale department of internal medicine faculty achievement award for outstanding clinical care in 2008. He was twice awarded the attending teacher the year by the Yale internal medicine housestaff, and receive the Aldo Bellucci teaching award from the University Connecticut internal medicine residency program in 2012. He was awarded the John K Springer Humanitarian Award by Hartford hospital in 2017. He served on the Cystic Fibrosis Lung Transplant Referral Guidelines Committee in 2018-2019.
Dr. McArdle received a degree in economics and preprofessional studies from the University of Notre Dame in his medical degree from the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed his internal medicine residency, chief residency, and pulmonary and critical care fellowship training at the Yale University School of Medicine.
As of January 2017, Dr. McArdle reported the following external relationships:
Funding for clinical trial expenses, paid to Connecticut Multispecialty Group, PC, from the following companies:
- Novartis, for a study comparing inhaled tobramycin powder with other inhaled antipseudomonal antibacterial therapy in patients with cystic fibrosis colonized with chronic respiratory Pseudomonas aeruginosa.
- Pharmaxis, for a study of inhaled mannitol in patients with cystic fibrosis, co-sponsored by the Cystic Fibrosis Foundation Therapeutic Development Network.
Dr. McArdle serves in significant roles with the following organization(s), receiving reimbursement or compensation as listed:
- American Lung Association, Executive Committee member for Connecticut Pulmonary Section, without compensation.
- Cystic Fibrosis Foundation, providing funding for salary support for the Therapeutic Development Program of the Marie and Raymond Beauregard Central Connecticut Adult Cystic Fibrosis Program. Dr. McArdle serves as the Director.
Jarrod M. Mosier, MD
Dr. Mosier is the Associate Program Director of the Critical Care Medicine fellowship within the Department of Medicine, Section of Pulmonary/Critical Care at The University of Arizona College of Medicine Tucson. He has a dual appointment with both the Departments of Emergency Medicine and Internal Medicine. Dr. Mosier is board certified by the American Board of Emergency Medicine.
He is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. His academic interests include advanced airway management, extracorporeal membrane oxygenation, resuscitation and critical care ultrasound.
Dr. Mosier earned a bachelor degree at Boise State University. He completed medical school at the University of Nevada School of Medicine and completed his residency in emergency medicine at the University of Arizona. After residency, Dr. Mosier completed a critical care medicine fellowship at the University of Arizona.
View my board certification status via ABMS Website
As of January 2017, Dr. Mosier reported the following external relationships:
Dr. Mosier serves in a significant role with the following organization, receiving reimbursement or compensation as listed:
- Society of Critical Care Medicine, At-Large Member of Emergency Medicine Section Steering Committee, without compensation.
Margaret A. Pisani, MD
Dr. Pisani is an Associate Professor of Medicine at Yale University and Fellowship Program Director in the Pulmonary, Critical Care and Sleep Medicine Section. She is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine.
Dr. Pisani is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, she has served in various capacities on peer review groups, grant study sections and advisory boards such as CHEST Foundation, American College of Chest Physicians, National Institutes of Health Clinical and Translational Science Award and Connecticut Thoracic Society. She serves as reviewer for seven prestigious science journals and on Heart & Lung: The Journal of Acute and Critical Care's editorial board. She is a longstanding member of the Association of Subspecialty Professors, Chest Foundation Community Service, American College of Chest Physicians, American Thoracic Society and Society for Critical Care Medicine.
Dr. Pisani's leadership roles at Yale have included service on the Graduate Medical Education Committee, Geriatric Section Chief Search Committee, Internship Selection Committee, Internal Medicine Research Advisory Panel and Physician Scientist Recruitment Committee. She has chaired the Pulmonary Fellowship curriculum, research advisory and milestone committees, and is a longstanding member of the Medical Intensive Care Unit committee.
With over 46 peer-reviewed original publications in prestigious scientific journals, Dr. Pisani's research focuses on improving care and outcomes of older critically ill patients, with a current focus on sleep in critically ill patients, its impact on delirium and other patient outcomes.
Dr. Pisani received her physics degree from Iona College, a master's degree in biomedical engineering from New Jersey Institute of Technology, her medical degree from Temple University and master's degree in public health in chronic disease epidemiology at Yale University.
As of January 2017, Dr. Pisani reported the following external relationships:
Dr. Pisani serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Chest Physicians, Chair of the Scientific Programming Committee, receiving reimbursement for travel expenses.
- American College of Chest Physicians, Member of Steering Committee for the Women's Health Network, receiving reimbursement for travel expenses.
Work funded by educational grants from not-for-profit organizations, paid to Yale University, from the following company:
- The Donaghue Foundation, a charitable trust which funds projects in research, science and human health, for work on the implementation of a sleep protocol in the Intensive Care Unit, receiving salary support and staff and other project expenses.